Hong Kong Banquet Market Shifts Toward Smaller-Scale Events, Runhotel.hk Data Shows

Hong Kong Banquet Market Shifts Toward Smaller-Scale Events, Runhotel.hk Data Shows

HONG KONG, Jan. 19, 2026 /PRNewswire/ -- According to banquet enquiry data from the past year collected by Runhotel.hk's "Venue Search" platform, Hong Kong's banquet market is undergoing a noticeable shift, driven primarily by changing wedding...

LightingWay Counselling Offers Affordable Therapy Amid Rising Job Market Uncertainty in Singapore

LightingWay Counselling Offers Affordable Therapy Amid Rising Job Market Uncertainty in Singapore

SINGAPORE, Dec. 17, 2025 /PRNewswire/ -- Recent employment data reveals heightened job market pressures affecting mental health needs. In light of these circumstances, LightingWay Counselling & Therapy continues to provide affordable therapy...

Celltrion announces publication of post-hoc analysis of LIBERTY-CD study of ZYMFENTRA®  (infliximab-dyyb), indicating consistent efficacy across disease location, including the terminal ileum in Clinical Gastroenterology and Hepatology journal

Celltrion announces publication of post-hoc analysis of LIBERTY-CD study of ZYMFENTRA®  (infliximab-dyyb), indicating consistent efficacy across disease location, including the terminal ileum in Clinical Gastroenterology and Hepatology journal

Findings from the post-hoc analysis of LIBERTY-CD study indicates efficacy of ZYMFENTRA® (subcutaneous infliximab) regardless of disease location, consistent across ileum-dominant and colon-dominant Crohn's disease (CD) Findings support the...

CYP-006TK Demonstrates Safety and Efficacy in DFU Clinical Trial

CYP-006TK Demonstrates Safety and Efficacy in DFU Clinical Trial

MELBOURNE, Australia, Dec. 5, 2024 /PRNewswire/ -- Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, has successfully completed its Phase 1 clinical trial...

menu
menu